Cardinal Health vs. McKesson: Which Pharmaceutical Giant Reigns Supreme?

Cardinal Health and McKesson are two pharmaceutical distributors with different strategic positioning. Cardinal Health is transitioning from restructuring to growth, leveraging specialty expansion and operational efficiency, while McKesson operates from a position of strength, refining its established platform. Cardinal Health has shown renewed momentum, with 19% revenue growth and 38% operating earnings rise, positioning it as an increasingly compelling investment opportunity. McKesson maintains steady execution with 11% revenue growth and 16% EPS rise, but its momentum appears more incremental than transformational.